Radiotherapy is utilized for therapeutic reasons in the early stages of cancer. It uses high-energy particles to destroy cancer cells' genetic material. Radiotherapy may be used with other cancer therapies, such as immunotherapy, chemotherapy, and surgery, to improve treatment success. Radiation treatment may be curative if the cancer is restricted to one location of the body. It may also be used in conjunction with other treatments to prevent tumor recurrence after initial melanoma removal surgery.
The rising number of cancer patients, technological developments, and high success rates of the treatment approach are important radiotherapy market growth drivers.?
In recent years, the global radiotherapy market
has witnessed a series of product launches and approvals that have contributed to its growth. DataM Intelligence's in-depth market analysis reveals the major market drivers, challenges, trends, and opportunities. Our market intelligence report evaluates the market size, growth, and share, providing crucial insights for businesses to make informed decisions and capitalize on the existing and upcoming opportunities in the radiotherapy market.
- The Radixact X9 Tomotherapy, which is integrated with the 2nd generation synchronized respiratory motion management system,?was?released in February 2022 by the Department of Radiation Oncology at Max Institute of Cancer Care (MICC), Saket, India. This radiation therapy treatment for cancer patients uses real-time monitoring and treatment delivery based on Artificial Intelligence (AI) to guarantee that the tumor is not missed owing to the?chest or abdominal breathing movement during radiation.
-
医科达
, a precision radiation therapy solution innovator, and GE Healthcare, a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures, signed a global commercial collaboration agreement in the field of radiation oncology in April 2022, allowing them to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy.
-
RefleXion Medical
, a cutting-edge therapeutic oncology corporation that uses biology-guided radiation (BgRT)* for all stages of cancer, held its inaugural conference in June 2022, focusing on the power of utilizing cancer biology to lead treatment planning and delivery for individualized radiotherapy. The symposium is the first event in the newly dedicated Sanjiv "Sam" Gambhir Memorial Learning Center at the firm.
- The International Atomic Energy Agency (IAEA) announced a plan in February 2022 to address a severe shortage of cancer care capacity in many low- and middle-income countries (LMICs), with an initial focus on Africa, where cancer mortality is higher due to a lack of access to potentially life-saving nuclear medicine and radiotherapy.
-
Accuray
Incorporated (US) introduced the CyberKnife S7 System in June 2020, a revolutionary device that combines speed, advanced precision, and real-time AI-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.
- In September 2019,
Varian
Medical Systems, Inc. (US), now Siemens Healthineers AG (Germany), made the ProBeam 360° proton treatment system (the smallest multi-room system currently for sale) accessible in a multi-room configuration.
-
For businesses, investors, and decision-makers in the radiotherapy market, conducting a thorough market analysis is crucial in staying ahead of the competition. By examining market drivers, challenges, and opportunities, recent developments stakeholders can comprehensively understand the current market landscape and future projections.
To Know More Download Sample??
